PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-50.42%
Negative net income growth while AVGO stands at 6.94%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
46.90%
D&A growth of 46.90% while AVGO is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
-1933.33%
Negative yoy deferred tax while AVGO stands at 58.87%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-29.03%
Negative yoy SBC while AVGO is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
98.12%
Slight usage while AVGO is negative at -150.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
972.73%
AR growth while AVGO is negative at -1175.00%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
822.73%
Inventory growth well above AVGO's 200.00%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
-61.54%
Both reduce yoy usage, with AVGO at -84.85%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-3600.00%
Both negative yoy, with AVGO at -58.97%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-14.67%
Both yoy CFO lines are negative, with AVGO at -8.45%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
20.73%
Some CapEx rise while AVGO is negative at -54.17%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-53.61%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-76.77%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
100.00%
Growth of 100.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
78.76%
We have mild expansions while AVGO is negative at -58.33%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
83.33%
Debt repayment growth of 83.33% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
284.85%
Stock issuance far above AVGO's 36.36%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
33.33%
Buyback growth at 50-75% of AVGO's 63.24%. Martin Whitman questions partial disadvantage in per-share enhancements if competitor repurchases more.